ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 1942

$516K Total Retail Price of All Prescriptions

Rank: 84 out of 1942

347 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 347 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 347 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,952 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LEVOTHYROXINE SODIUM 557 530 1 3
AMLODIPINE BESYLATE 414 390 2 6
SIMVASTATIN 410 400 3 1
OMEPRAZOLE 395 369 4 4
FUROSEMIDE 380 375 5 5
ATORVASTATIN CALCIUM 353 341 6 14
METOPROLOL SUCCINATE 351 341 7 13
POTASSIUM CHLORIDE 224 200 8 17
LOSARTAN POTASSIUM 215 215 9 18
METOPROLOL TARTRATE 213 179 10 9
LISINOPRIL 206 204 11 2
METFORMIN HCL 205 171 12 10
WARFARIN SODIUM 194 194 13 11
CARVEDILOL 165 155 14 39
CRESTOR 140 134 15 34
TAMSULOSIN HCL 129 129 16 29
ALLOPURINOL 126 126 17 26
HYDROCHLOROTHIAZIDE 118 118 18 8
POLYETHYLENE GLYCOL 3350 118 104 18 28
PREDNISONE 111 103 20 27
HYDROCODONE-ACETAMINOPHEN 109 79 S3 21 12
OXYCODONE HCL 108 97 S2 22 52
LOSARTAN-HYDROCHLOROTHIAZIDE 95 95 23 67
FENTANYL 89 78 S2 24 47
LYRICA 89 68 24 144
ATENOLOL 86 86 26 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 86 26 22
SPIRONOLACTONE 86 70 26 59
CLOPIDOGREL 83 74 29 55
DILTIAZEM ER 80 71 30 121
GABAPENTIN 80 74 30 16
BYSTOLIC 79 79 32 169
CITALOPRAM HBR 79 61 32 15
ZOLPIDEM TARTRATE 78 74 34 25
SERTRALINE HCL 78 71 34 20
VOLTAREN 75 72 36 206
RANITIDINE HCL 75 68 36 31
ENALAPRIL MALEATE 71 47 38 89
JANUVIA 69 57 39 85
ROPINIROLE HCL 66 53 40 96
TRAMADOL HCL 63 58 41 19
ZETIA 63 55 41 75
GLIMEPIRIDE 60 48 43 53
MELOXICAM 59 56 44 81
TRICOR 59 46 44 174
DONEPEZIL HCL 58 54 46 30
DIOVAN 57 54 47 44
KLOR-CON M10 56 56 48 148
NEXIUM 56 46 48 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.